{"id":"W2067389932","doi":"10.1007/s11239-015-1167-9","title":"Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents","year":2015,"lang":"en","type":"review","venue":"Journal of Thrombosis and Thrombolysis","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Dabigatran; Rivaroxaban; Idarucizumab; Apixaban; Anticoagulant; Hemostasis; Recombinant factor VIIa; Intensive care medicine; Prothrombin complex concentrate; Clinical trial; Surgery; Warfarin; Internal medicine; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002353822,0.0006062147,0.004449555,0.0008545688,0.0002580876,0.0001952908,0.0003037506,0.0003619902,0.0004247197],"category_scores_gemma":[0.0001330017,0.0004155312,0.001160668,0.0007018526,0.00009368082,0.0004314554,0.0002423741,0.0007759373,0.00003272648],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004821974,"about_ca_system_score_gemma":0.0001184285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005277528,"about_ca_topic_score_gemma":5.318299e-7,"domain_scores_codex":[0.9960179,0.0004348962,0.001582926,0.0004754334,0.001033928,0.0004548609],"domain_scores_gemma":[0.9968672,0.0001821472,0.001954856,0.0002563178,0.0002905179,0.0004489902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004259898,0.0008925477,0.00950451,0.00626529,0.03454773,0.0007990705,0.0007854159,0.0001223378,0.0003613931,0.001007186,0.062235,0.8830535],"study_design_scores_gemma":[0.002873649,0.001089778,0.00349775,0.008449225,0.02192271,0.0000859718,0.0002481862,0.0003302213,0.00001173314,0.0003436348,0.9603878,0.0007593491],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01234339,0.982374,0.0001243002,0.001414824,0.001967222,0.0008841868,0.00003786957,0.00008282947,0.0007713457],"genre_scores_gemma":[0.008243609,0.9887305,0.001036395,0.000199631,0.00151514,0.000001389231,0.0001054496,0.00007672278,0.0000911676],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8981528,"threshold_uncertainty_score":0.9998296,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3764813194623995,"score_gpt":0.4686779600898817,"score_spread":0.09219664062748223,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}